Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial
Titel:
Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial
Auteur:
Moses, Jeffrey W. Nikolsky, Eugenia Mehran, Roxana Cambier, Patrick A. Bachinsky, William B. Leya, Fred Kuntz, Richard E. Popma, Jeffrey J. Schleckser, Patricia Wang, Hong Cohen, Sidney A. Leon, Martin B.